NPM1-mutated AML: One entity, multiple layers of heterogeneity.
Nucleophosmin 1 (NPM1) mutations are found in around one third of all acute myeloid leukaemias (AMLs). However, little is known about the clinical role of the rare, non-A NPM1 variants. Sangiorgio et al. showed that rare variants shared a similar molecular background and overall survival to the common type A, with FMS-...